Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Syndrome , respiratory

N.A. Essential oil, phthalides, terpenoids.100 Prevent bone marrow loss, treat acquired immune deficiency syndrome, respiratory tract infections, hypertension, Parkinson s disease, and hepatitis. [Pg.212]

Clozapine causes a particularly high rate of grand mal seizures, estimated at 4% to 5% in the first year. This is a very serious hazard. The drug frequently produces severe low blood pressure and increased heart rate, potentially resulting in cardiovascular collapse. It can also cause hypertension. It can cause fever and a flulike syndrome. Respiratory arrest... [Pg.26]

Adult respiratory distress syndrome Respiratory failure... [Pg.59]

ECMO is considered a standard therapy for the treatment of respiratory failure in neonatal patients (Anderson and Bartlett, 2000). In adult and pediatric patients, it is a treatment of last resort for individuals who would otherwise die despite maximal therapy (Anderson and Bartlett, 2000 Bartlett et al., 2000). Even in neonatal cases, ECMO is a therapy reserved for those patients with severe respiratory compromise and a high risk of death who are failing traditional ventilator-based interventions. Common causes of respiratory failure in the neonatal population that are treatable with ECMO support include pneumonia or sepsis, meconium aspiration syndrome, respiratory distress syndrome, persistent fetal circulation, and congenital diaphragmatic hernia (Anderson and Bartlett, 2000). Contraindications to ECMO support include root causes that are unresolvable, such as a major birth defect or genetic abnormality, and comorbid conditions such as intracranial hemorrhage or fetal underdevelopment that suggest a poor outcome (Anderson and Bartlett, 2000). Indications for ECMO use in the pediatric and adult populations are not dissimilar from those of the neonate, but... [Pg.524]

Serious adverse events dependency, abuse, withdrawal syndrome, respiratory failure, seizures, depression, hypersensitivity reaction. [Pg.367]

The oil is widely used externally for wound healing purposes. Internally, it is recommended for its anthelminthic effects, for jaundice, irritable bowel syndrome, respiratory infections, gynaecological diseases and as a contraceptive [36]. [Pg.312]

MRSA and VRSA Skin and soft tissues, toxic shock syndrome, respiratory tract and blood, indwelling devices, implants Trimethoprim, sulfamethoxazole, minocycUne, quinupristin-dalfopristin, daptomydn, UnezoUd, tigecycUne, vancomycin... [Pg.187]

In low doses, inhaled NO may have a beneficial therapeutic effect, since NO in the inspired air leads to pulmonary vasodilation. In persistent pulmonary hypertension of the newborn, NO inhalation has already been used with some success. NO inhalation as the treatment for acute respiratory distress syndrome, however, has been disappointing. Only transient improvements of oxygenation were detected and the outcome of placebo-controlled trials did not show any improvement... [Pg.575]

PA S1 S01.131 Neutrophil elastase Drug target for emphysema, cystic fibrosis, adult respiratory distress syndrome, rheumatoid arthritis and other diseases... [Pg.880]

In the past number of years a number of studies have shown that in a variety of diseases there is a significant oxidation of Met residues to Met(O) in specific proteins that results in a loss of biological activity. These diseases include cataracts, rheumatoid arthritis, adult respiratory distress syndrome and emphysema. The most convincing evidence that Met(O) in proteins may be involved in the etiology of a pathological condition comes from studies with a-l-PI. It is well accepted that a-l-PI is inactivated upon oxidation of its Met residues. A decreased activity of a-l-PI in lung tissue that would result in an increased elastase activity has been associated with pulmonary emphysema. In patients who have a... [Pg.866]

This complex consists of at least 25 separate polypeptides, seven of which are encoded by mtDNA. Its catalytic action is to transfer electrons from NADH to ubiquinone, thus replenishing NAD concentrations. Complex I deficiency has been described in myopathic syndromes, characterized by exercise intolerance and lactic acidemia. In at least some patients it has been demonstrated that the defect is tissue specific and a defect in nuclear DNA is assumed. Muscle biopsy findings in these patients are typical of those in many respiratory chain abnormalities. Instead of the even distribution of mitochondria seen in normal muscle fibers, mitochondria are seen in dense clusters, especially at the fiber periphery, giving rise to the ragged-red fiber (Figure 10). This appearance is a hallmark of many mitochondrial myopathies. [Pg.308]

This complex consists of four subunits, all of which are encoded on nuclear DNA, synthesized on cytosolic ribosomes, and transported into mitochondria. The succinate dehydrogenase (SDH) component of the complex oxidizes succinate to fumarate with transfer of electrons via its prosthetic group, FAD, to ubiquinone. It is unique in that it participates both in the respiratory chain and in the tricarboxylic acid (TC A) cycle. Defects of complex II are rare and only about 10 cases have been reported to date. Clinical syndromes include myopathy, but the major presenting features are often encephalopathy, with seizures and psychomotor retardation. Succinate oxidation is severely impaired (Figure 11). [Pg.309]

Personality variables, state of mind at time of withdrawal, and expectations of severity of symptoms all may affect withdrawal severity (Kleber 1981). One study found that merely providing addicts information about the withdrawal syndrome resulted in lower levels of withdrawal symptoms (Green and Gos-sop 1988). Naloxone rapidly induces a severe withdrawal syndrome, which peaks within 30 minutes and then declines rapidly. Until the antagonist is eliminated, only partial suppression of the withdrawal syndrome is possible, and then only by using very high opioid doses, which may cause respiratory depression when naloxone is metabolized. [Pg.71]

A new coronavirus was quickly identified after the outbreak of an atypical pneumonia in southern China early in 2003. The new virus eventually caused 8,000 infections with approximately 800 deaths in 29 countries. The condition was named Severe Acute Respiratory Syndrome, SARS, and the causative coronavirus named SARS-CoV. The zoonotic nature of the infection came with the identification of a similar virus in bats (Poon et al. 2005), although it is possible that the bat virus passed through other animal hosts and recombined with other SARS-like coron-aviruses prior to infecting humans (Hon et al. 2008). SARS-CoV is not currently circulating in the human population however, the mysterious appearance and rapid spread of this virus emphasized how vulnerable the human population is to such respiratory infections. This has spurred interest in the development of antivirals that could be used either in treatment or as prophylaxis to complement public health measures in curbing future outbreaks. [Pg.101]

SARS-CoV Severe acute respiratory syndrome coronavirus... [Pg.156]


See other pages where Syndrome , respiratory is mentioned: [Pg.277]    [Pg.2126]    [Pg.378]    [Pg.277]    [Pg.2126]    [Pg.378]    [Pg.37]    [Pg.389]    [Pg.196]    [Pg.6]    [Pg.78]    [Pg.139]    [Pg.165]    [Pg.203]    [Pg.353]    [Pg.480]    [Pg.874]    [Pg.277]    [Pg.372]    [Pg.410]    [Pg.868]    [Pg.14]    [Pg.296]    [Pg.304]    [Pg.311]    [Pg.313]    [Pg.323]    [Pg.543]    [Pg.1952]    [Pg.147]    [Pg.250]    [Pg.34]    [Pg.119]    [Pg.9]    [Pg.105]    [Pg.155]   


SEARCH



Acute diseases respiratory distress syndrome

Acute respiratory distress syndrome

Acute respiratory distress syndrome ARDS)

Acute respiratory distress syndrome animal models

Acute respiratory distress syndrome clinical features

Acute respiratory distress syndrome clinical presentation

Acute respiratory distress syndrome corticosteroids

Acute respiratory distress syndrome evaluation

Acute respiratory distress syndrome monitoring

Acute respiratory distress syndrome nitric oxide

Acute respiratory distress syndrome pathophysiology

Acute respiratory distress syndrome pulmonary edema

Acute respiratory distress syndrome treatment

Adult respiratory distress syndrom

Adult respiratory distress syndrome

Adult respiratory distress syndrome ARDS)

Adult respiratory distress syndrome neutrophils

Adult respiratory syndrome

Infant respiratory distress syndrome

Late respiratory systemic syndrome

Neonatal respiratory distress syndrome

Neonatal respiratory distress syndrome prevention

Newborn respiratory distress syndrome

Periengraftment respiratory distress syndrome

Respiratory distress syndrom

Respiratory distress syndrome

Respiratory distress syndrome lipid metabolism

Respiratory distress syndrome, neonates

Respiratory distress syndrome, surfactant

Respiratory distress syndrome, surfactant deficiency causing

Respiratory system syndrome

Sepsis acute respiratory distress syndrome

Severe acute respiratory distress syndrome

Severe acute respiratory syndrome

Severe acute respiratory syndrome SARS)

Severe acute respiratory syndrome coronavirus

Severe acute respiratory syndrome treatment

© 2024 chempedia.info